Analysis of data from randomised statin trials finds that statin users have a 13% increased risk of diabetes

This paper was published in Diabetes Care 2009 Oct;32(10):1924-9

 

Study title and authors:

Statin therapy and risk of developing type 2 diabetes: a meta-analysis.

Rajpathak SN, Kumbhani DJ, Crandall J, Barzilai N, Alderman M, Ridker PM.

Department of Epidemiology and Population Health and Department of Medicine, Albert Einstein College of Medicine, New York, New York. srajpath@aecom.yu.edu

 

This paper can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/19794004/

This paper is a meta-analysis of randomised statin trials that evaluated the effect of statin therapy on diabetes risk. The researchers conducted a systematic literature search for randomised statin trials that reported data on diabetes. They found six trials which included 57,593 patients with an average follow-up of 3.9 years during which 2,082 diabetes cases accrued.

This analysis of six randomised statin trials found that statin use was associated with a 13% increase in the incidence of diabetes.